At-Risk for Type 1 Diabetes Extension Study (TN-10 Extension)
Clinical trial NCT04270942 · COMPLETED
Trial details
- NCT number
- NCT04270942
- Sponsor
- Provention Bio, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-26
- Primary completion
- 2024-01-22
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.